B+
Bull case
25%
Probability
Target price
$315.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
CRL
Charles River Laboratories InternationalBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The Q2 print appears better than the packet’s pre-release Zacks estimates of $970.8 million revenue and $2.72 non-GAAP EPS, while the company raised full-year guidance and reported improving DSA demand and a multiyear-high book-to-bill [#PR-EARNINGS-2026-07-30] [#SEC-8K-2026-08-05].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +8.2.
What can break
Divestiture-related losses and portfolio restructuring may continue to distort GAAP earnings and execution.
Momentum
90
Value
60
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $282.00 · Bull $315.00 · Bear $220.00Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $291.46
Why
Momentum90 · Δ7d -5.3
Value60 · Δ7d -0.0
Sentiment64 · Δ7d +8.2
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +8.2.
Contradictions & invalidation
- • Divestiture-related losses and portfolio restructuring may continue to distort GAAP earnings and execution.
- • Higher DSA study-related direct costs and corporate expenses could delay margin recovery.
- • RMS remains weak, DSA costs compressed non-GAAP margins, and the GAAP result included a $63.7 million divestiture-related loss.
Catalyst clock
2026-08-05
Q2 results and FY2026 guidance raise
Lead driver: Sentiment · See AI snapshot
Momentum
90
9% active weight
Current posture
7d trendSoftening
Δ7d
-5.3
Δ21d
-4.7
Value
60
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.2
Sentiment
64
62% active weight
Current posture
7d trendImproving
Δ7d
+8.2
Δ21d
+4.3
Why this grade
Composite grade B. Momentum 90.3 / Value 60.1 / Sentiment 64.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$282.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$220.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$13.68B
Beta
1.63
Shares Out
47.74M
P/E (TTM) · Derived
-98.4
P/S (TTM)
2.55
P/FCF (TTM)
18.86
Rev YoY
-2.7%
EPS YoY
-102.9%
Gross Margin
+32.6%
Op Margin
+13.5%
Net Debt
$2.42B
Current Ratio
1.35
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data